|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Impact of skeletal complications on patients' quality of life, mobility, and functional independence显示文摘 | Costa L Badia X Chow E Lipton A Wardley A | 2008 | Support Care Cancer2008，16，8： | 1 |
| 2 | New perspcctives on glaucoma显示文摘 | Dreyer E B Lipton S A | 1999 | JAMA1999，281，4： | 1 |
| 3 | Molecular basis of glaucomate toxity in retina fang lion cells 显示文摘 | Sucher N J Lipton S A Dreyer E B | 1997 | Vision Res1997，37，24： | 1 |
| 4 | Human ingestion of a 'superwarfarin' rodenticide resulting in a prolonged anticoagulant effect显示文摘 | LIPTON R A KLASS E M | 1984 | JAMA1984，252，： | 1 |
| 5 | The new bisphosphonate, Zometa (zoledronic acid) , decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate 显示文摘 | Lipton A Small E Saad E | 2002 | Cancer Invest2002，20，2： | 1 |
| 6 | Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and el crated bone resorption receiving zoledronic acid显示文摘 | Lipton A Cook R Saad F Major P Garnero P Terpos E | 2008 | Cancer2008，113，： | 1 |
| 7 | Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions显示文摘 | HERTTUALA S Y LIPTON B A ROSENFELD M E | 1991 | Proc NatlAcad1991，88，12： | 1 |
| 8 | Anti-inflammatory activity of alphaMSH (11 - 13 ) analogs: influences of alteration in stereochemistry 显示文摘 | Hihz M E Catania A Lipton J M | 1991 | Peptides1991，12，4： | 1 |
| 9 | The new bisphosphonate, Zometa (zoledronie acid), decreases skeletal complications in both osteolyt- ic and osteoblastic lesions:a comparison to pamidronate 显示文摘 | Lipton A Small E Saad F et at | 2002 | Cancer Invest2002，20，2： | 1 |
| 10 | The new bisphonate,Zometa ( Zoledronic acid) decreases skeletal comp lications in both lyric and blastic lesions: a compsdsion to pamidronate显示文摘 | Lipton A S&mlf E Saad P | 2001 | Cancer Invest2001，20，1： | 1 |
| 11 | Markers of bone resorption in patients treated with pamidronate显示文摘 | Lipton A Demers L Curley E | 1998 | European Journal of Cancer1998，34，13： | 1 |
| 12 | The new bisphosphonate,Zometa(zoledronic acid),decreases skeletal complications in both osteolyticand osteoblastic lesions:a comparison to pamidronate显示文摘 | Lipton A Small E Saad E | 2002 | Cancer Invest2002，20，2： | 1 |
| 13 | Dementia associated with the acquired immunodeficiency syndrome显示文摘 | Gendelman H E | 1995 | N Eng J Med1995，332，14： | 1 |
| 14 | Role of bisphosphonates for the mangement of skeletal complications and bone pain from skeletal metastases显示文摘 | Costa L Lipton A Coleman R E | 2006 | Suppot Cancer Ther2006，3，3： | 1 |
| 15 | The new bisphosphonate,zometa,decreases skeletal complication in both osteolytic and osteoblastic lesions:a comparison to pamidronate显示文摘 | Lipton A Small E Saad F | 2002 | Cancer Invest2002，20，2： | 1 |
| 16 | Human ingestion of a‘superwarfarin’rodenticide resulting in a prolongedanticoagulant effect显示文摘 | Lipton R A Klass E M | 1984 | JAMA1984，252，： | 1 |
| 17 | Serum 1-OH vi- tamin D and prognosis of postmenopausal breast cancer patients: NCIC-CTG MA 14 trial 显示文摘 | Piura E Chapman JW Lipton A | 2009 | J Clin Oncol2009，27，1： | 1 |
| 18 | Molecular basis of glutamate toxicity in retinal ganglion cells显示文摘 | Sucher N J Lipton S A Dreye E B | 1977 | Vision Res1977，37，16： | 1 |
| 19 | Markers of Bone Resorption in Patients Treated with Pamidronate显示文摘 | Lipton A Demers L Curley E | 1998 | Eur J Cancer1998，34，13： | 1 |
| 20 | Molecular basis of glutamate toxicity in retinal ganglion cells显示文摘 | Sucher N J Lipton S A Dreyer E B | 1997 | Vis Res1997，37，24： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员